trending Market Intelligence /marketintelligence/en/news-insights/trending/i2Z2jhEeTiTYP4h-Ri0hmw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

AnaptysBio prices common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


AnaptysBio prices common stock offering

AnaptysBio Inc. priced an underwritten public offering of 3 million common shares at $68.50 apiece for expected gross proceeds of $205.5 million.

The company granted underwriters an option to buy up to an additional 450,000 shares.

The offering is expected to close Oct. 17, subject to customary closing conditions.

Credit Suisse, Jefferies and Stifel are acting as joint book-running managers for the offering, with Wedbush PacGrow, Baird and SunTrust Robinson Humphrey as co-managers.